Creatine Kinase (CK), MB
Also known as: CK-2, CK-MB
Use
Confirm and monitor therapy after acute myocardial infarction
Special Instructions
Not provided.
Limitations
CK-MB levels might reflect skeletal muscle injury rather than myocardial damage. Surprisingly low baseline levels might be found in the elderly. Random single CK-MB measurements cannot definitively confirm or rule out AMI; serial measurements over time are advised in the emergency room setting and during treatment.
Methodology
Immunoassay (ECLIA)
Biomarkers
Creatine Kinase-MB
Analyte
LOINC Codes
- 13969-1 - CK MB SerPl-mCnc
- 13969-1 - CK MB SerPl-mCnc
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.7 mL
Container
Gel-barrier tube (preferred) or red-top tube
Collection Instructions
If a red-top tube is used, transfer separated serum to a plastic transport tube.
Storage Instructions
Room temperature
Causes for Rejection
Citrate plasma specimen; improper labeling
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 day |
| Refrigerated | 14 days |
| Frozen | 14 days |
Other tests from different labs that may be relevant
